Blau Farmacêutica S.A. (BLAU3.SA)
BRL 12.57
(-5.42%)
BRL 12.57
(-5.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.37 Billion | 1.4 Billion | 1.36 Billion | 1.18 Billion | 977.5 Million | 782.16 Million |
| Cost of Revenue | 908.33 Million | 739.03 Million | 700.47 Million | 625.83 Million | 547.43 Million | 443.9 Million |
| Gross Profit | 464.3 Million | 667.87 Million | 665.93 Million | 555.96 Million | 430.06 Million | 338.25 Million |
| Operating Expenses | 252.76 Million | 215.68 Million | 207.18 Million | 166.28 Million | 128.77 Million | 135.24 Million |
| Selling, General and Administrative Expenses | 210.36 Million | 213.84 Million | 201.76 Million | 132.81 Million | 115.23 Million | 127.13 Million |
| Research and Development Expenses | 42.39 Million | 38.91 Million | 52.11 Million | 28.53 Million | 11.95 Million | 15.28 Million |
| Other Expenses | - | - | - | - | - | -1.74 Million |
| Cost and Expenses | 1.16 Billion | 954.71 Million | 907.65 Million | 792.12 Million | 676.21 Million | 579.14 Million |
| Operating Income | 211.53 Million | 512.6 Million | 490.23 Million | 366.9 Million | 301.29 Million | 194.83 Million |
| Interest Expense | 37.58 Million | 32.43 Million | 26.79 Million | 15.31 Million | 15.11 Million | 17.25 Million |
| Income Tax Expense | 86.74 Million | 108.06 Million | 158.6 Million | 99.31 Million | 86.12 Million | 55.14 Million |
| Earnings before Tax | 334.07 Million | 468.56 Million | 482.46 Million | 353.64 Million | 286.36 Million | 178.4 Million |
| Net Income | 249.8 Million | 363.36 Million | 325.22 Million | 254.33 Million | 200.23 Million | 123.25 Million |
| Earnings Per Share Basic | 1.41 | 2.02 | 1.81 | 1.45 | 1.35 | 0.70 |
| Earnings Per Share Diluted | 1.41 | 2.02 | 1.81 | 1.45 | 1.35 | 0.70 |
| Weighted Average Shares Outstanding | 177.68 Million | 179.39 Million | 179.39 Million | 175.29 Million | 148 Million | 175.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 177.68 Million | 179.39 Million | 179.39 Million | 175.29 Million | 148.12 Million | 175.29 Million |
| Gross Margin | 0.34 | 0.47 | 0.49 | 0.47 | 0.44 | 0.43 |
| EBIT Margin | 0.30 | 0.38 | 0.37 | 0.32 | 0.32 | 0.26 |
| Profit Margin | 0.18 | 0.26 | 0.24 | 0.22 | 0.20 | 0.16 |
| EBITDA | 410.54 Million | 527.03 Million | 533.3 Million | 388.7 Million | 312.5 Million | 206.75 Million |
| Earnings Before Tax Margin | 0.15 | 0.36 | 0.36 | 0.31 | 0.31 | 0.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 465.1 Million | 359.68 Million | 1.37 Billion | 387.47 Million | 362.64 Million | 364.3 Million |
| Cost of Revenue | 300.05 Million | 248.3 Million | 908.33 Million | 276.2 Million | 251.42 Million | 212.69 Million |
| Gross Profit | 165.04 Million | 111.38 Million | 464.3 Million | 111.27 Million | 111.22 Million | 151.61 Million |
| Operating Expenses | 83.34 Million | 69.55 Million | 252.76 Million | 69.15 Million | 193.16 Million | 64.82 Million |
| Selling, General and Administrative Expenses | 75.74 Million | 64.01 Million | - | 55.84 Million | 72.35 Million | 64.58 Million |
| Research and Development Expenses | 7.6 Million | 5.53 Million | - | 13.3 Million | 8.94 Million | 10.91 Million |
| Other Expenses | 9.61 Million | - | - | - | - | - |
| Cost and Expenses | 383.4 Million | 317.85 Million | 1.16 Billion | 345.35 Million | 444.58 Million | 277.51 Million |
| Operating Income | 81.69 Million | 41.82 Million | 211.53 Million | 42.11 Million | -71.77 Million | 98.51 Million |
| Interest Expense | 23.74 Million | 15.02 Million | 37.58 Million | 17.79 Million | 12.64 Million | 11.12 Million |
| Income Tax Expense | 9.55 Million | 7.91 Million | 86.74 Million | 11.08 Million | 50.84 Million | 16.73 Million |
| Earnings before Tax | 57.17 Million | 47.58 Million | 334.07 Million | 37.98 Million | -91.84 Million | 86.84 Million |
| Net Income | 48.73 Million | 40.09 Million | 249.8 Million | 27.67 Million | 99.39 Million | 70.78 Million |
| Earnings Per Share Basic | 0.27 | 0.23 | - | 0.16 | 0.56 | 0.40 |
| Earnings Per Share Diluted | 0.27 | 0.23 | - | 0.16 | 0.56 | 0.40 |
| Weighted Average Shares Outstanding | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million | 177.68 Million |
| Gross Margin | 0.35 | 0.31 | 0.34 | 0.29 | 0.31 | 0.42 |
| EBIT Margin | 0.19 | 0.15 | - | 0.14 | -0.17 | 0.29 |
| Profit Margin | 0.10 | 0.11 | 0.18 | 0.07 | 0.27 | 0.19 |
| EBITDA | 89.5 Million | 53.84 Million | - | 54.63 Million | -60.16 Million | 106.41 Million |
| Earnings Before Tax Margin | 0.18 | 0.12 | 0.15 | 0.11 | -0.20 | 0.27 |
SHV
023800
BG
600773
BEEN
HGINFRA